Real estate group creating $1.1B gene therapy CDMO at former GSK site

23rd January 2020 Uncategorised 0

The real estate impresario that built a chain of upscale drug recovery facilities is now jumping on a new trend. Brian O’Neil’s MLP Ventures says it is creating a CDMO and building a $1.1 billion gene and cell treatment manufacturing operation in a former GlaxoSmithKline site near Philadelphia.

More: Real estate group creating .1B gene therapy CDMO at former GSK site
Source: fierce